Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor Necrosis Factor α Blockade: An Opportunity to Tackle Breast Cancer
María F. Mercogliano, Sofía Bruni, Patricia V. Elizalde, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study
Hui Yu, Liangbin Lin, Zhiqiang Zhang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 1303
NF‐κB signaling in inflammation and cancer
Tao Zhang, Chao Ma, Zhiqiang Zhang, et al.
MedComm (2021) Vol. 2, Iss. 4, pp. 618-653
Open Access | Times Cited: 287
Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer
Feng Ye, Saikat Dewanjee, Yuehua Li, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 267
3D Tumor Models and Their Use for the Testing of Immunotherapies
Nicolas Boucherit, Laurent Gorvel, Daniel Olive
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 140
Protein cargo in extracellular vesicles as the key mediator in the progression of cancer
Klára Hánělová, Martina Raudenská, Michal Masařík, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 28
Harnessing Tumor Necrosis Factor Alpha to Achieve Effective Cancer Immunotherapy
María F. Mercogliano, Sofía Bruni, Florencia Mauro, et al.
Cancers (2021) Vol. 13, Iss. 3, pp. 564-564
Open Access | Times Cited: 79
The Interplay between Oxidative Stress, Inflammation and Angiogenesis in Bladder Cancer Development
Paulina Wigner, Radosław Grębowski, Michał Bijak, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4483-4483
Open Access | Times Cited: 73
Epithelial-to-Mesenchymal Transition Signaling Pathways Responsible for Breast Cancer Metastasis
Busra Buyuk, Sha Jin, Kaiming Ye
Cellular and Molecular Bioengineering (2021) Vol. 15, Iss. 1, pp. 1-13
Open Access | Times Cited: 68
Molecularly Imprinted Polymer-Based Electrochemical Sensors for the Diagnosis of Infectious Diseases
Greta Pilvenyte, Vilma Ratautaitė, Raimonda Bogužaitė, et al.
Biosensors (2023) Vol. 13, Iss. 6, pp. 620-620
Open Access | Times Cited: 36
Tumor-associated macrophages induce inflammation and drug resistance in a mechanically tunable engineered model of osteosarcoma
Letitia K. Chim, Isabelle L. Williams, Caleb J. Bashor, et al.
Biomaterials (2023) Vol. 296, pp. 122076-122076
Closed Access | Times Cited: 23
Cellular heterogeneity in TNF/TNFR1 signalling: live cell imaging of cell fate decisions in single cells
Marcus K Preedy, Michael White, Vinay Tergaonkar
Cell Death and Disease (2024) Vol. 15, Iss. 3
Open Access | Times Cited: 15
Exploration of tumor growth regression of quinoa and chia oil nanocapsules via the control of PIK3CA and MYC expression, anti-inflammation and cell proliferation inhibition, and their hepatorenal safety in rat breast cancer model
Aida I. El Makawy, Sekena H. Abdel‐Aziem, Shaimaa Mohammed, et al.
Bulletin of the National Research Centre/Bulletin of the National Research Center (2024) Vol. 48, Iss. 1
Open Access | Times Cited: 9
Cytokines in oncolytic virotherapy
Jonathan Pol, Samuel T. Workenhe, Prathyusha Konda, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 56, pp. 4-27
Open Access | Times Cited: 53
Frontiers in cancer immunotherapy—a symposium report
Jennifer Cable, Benjamin Greenbaum, Dana Pe’er, et al.
Annals of the New York Academy of Sciences (2020) Vol. 1489, Iss. 1, pp. 30-47
Closed Access | Times Cited: 53
Pro-angiogenic activity and vasculogenic mimicry in the tumor microenvironment by leptin in cancer
Ana K. Herrera-Vargas, Eduardo García-Rodríguez, Monserrat Olea‐Flores, et al.
Cytokine & Growth Factor Reviews (2021) Vol. 62, pp. 23-41
Closed Access | Times Cited: 47
Silver Nanoparticle-Coated Ethyl Cellulose Inhibits Tumor Necrosis Factor-α of Breast Cancer Cells
Ahmed A. H. Abdellatif, Mansour Alsharidah, Osamah Al Rugaie, et al.
Drug Design Development and Therapy (2021) Vol. Volume 15, pp. 2035-2046
Open Access | Times Cited: 42
Cancer-Associated Fibroblasts Promote Radioresistance of Breast Cancer Cells via the HGF/c-Met Signaling Pathway
Baiyao Wang, Wei Liu, Chunshan Liu, et al.
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 116, Iss. 3, pp. 640-654
Open Access | Times Cited: 28
Unveiling the Immune Microenvironment’s Role in Breast Cancer: A Glimpse into Promising Frontiers
Amalia Kotsifaki, Nektarios Alevizopoulos, Vassiliki Dimopoulou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15332-15332
Open Access | Times Cited: 21
Serum cytokines and neutrophil-to-lymphocyte ratio as predictive biomarkers of benefit from PD-1 inhibitors in gastric cancer
Yidan Hou, Xiaoli Li, Yudan Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
Oleic acid inhibits the migration and invasion of breast cancer cells with stemness characteristics through oxidative stress-mediated attenuation of the FAK/AKT/NF-κB pathway
Ji Soo Kim, Dae Kyeong Kim, Jeong Young Moon, et al.
Journal of Functional Foods (2024) Vol. 116, pp. 106224-106224
Open Access | Times Cited: 6
HOX genes and the NF-κB pathway: A convergence of developmental biology, inflammation and cancer biology
Priya Pai, Saraswati Sukumar
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2020) Vol. 1874, Iss. 2, pp. 188450-188450
Closed Access | Times Cited: 47
Tumor Necrosis Factor α: Taking a Personalized Road in Cancer Therapy
Adit Ben‐Baruch
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 27
Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
María Luisa Sánchez-León, Carlos Jiménez‐Cortegana, Silvia Silva Romeiro, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5208-5208
Open Access | Times Cited: 13
At the Crossroads of TNF α Signaling and Cancer
Sonal M. Manohar
Current Molecular Pharmacology (2023) Vol. 17
Open Access | Times Cited: 13
The potential role of targeting the leptin receptor as a treatment for breast cancer in the context of hyperleptinemia: a literature review
Abbas S. Neamah, Al-Hassan Soliman Wadan, Fadhel M. Lafta, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top